146 related articles for article (PubMed ID: 12165169)
1. Continuous monitoring of the subcutaneous glucose level in freely moving normal and diabetic rats and in humans with type 1 diabetes.
Jamali R; Ludvigsson J; Mohseni S
Diabetes Technol Ther; 2002; 4(3):305-12. PubMed ID: 12165169
[TBL] [Abstract][Full Text] [Related]
2. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
Hay LC; Wilmshurst EG; Fulcher G
Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
[TBL] [Abstract][Full Text] [Related]
3. Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.
Heptulla RA; Allen HF; Gross TM; Reiter EO
Pediatr Diabetes; 2004 Mar; 5(1):10-5. PubMed ID: 15043684
[TBL] [Abstract][Full Text] [Related]
4. The Medtronic Minimed Gold continuous glucose monitoring system: an effective means to discover hypo- and hyperglycemia in children under 7 years of age.
Gandrud LM; Xing D; Kollman C; Block JM; Kunselman B; Wilson DM; Buckingham BA
Diabetes Technol Ther; 2007 Aug; 9(4):307-16. PubMed ID: 17705686
[TBL] [Abstract][Full Text] [Related]
5. Continuous glucose monitoring and intensive treatment of type 1 diabetes.
; Tamborlane WV; Beck RW; Bode BW; Buckingham B; Chase HP; Clemons R; Fiallo-Scharer R; Fox LA; Gilliam LK; Hirsch IB; Huang ES; Kollman C; Kowalski AJ; Laffel L; Lawrence JM; Lee J; Mauras N; O'Grady M; Ruedy KJ; Tansey M; Tsalikian E; Weinzimer S; Wilson DM; Wolpert H; Wysocki T; Xing D
N Engl J Med; 2008 Oct; 359(14):1464-76. PubMed ID: 18779236
[TBL] [Abstract][Full Text] [Related]
6. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycemia: the guardian continuous monitoring system.
Bode B; Gross K; Rikalo N; Schwartz S; Wahl T; Page C; Gross T; Mastrototaro J
Diabetes Technol Ther; 2004 Apr; 6(2):105-13. PubMed ID: 15117576
[TBL] [Abstract][Full Text] [Related]
7. [Accuracy, utility and complications of continuous glucose monitoring system (CGMS) in pediatric patients with type 1 diabetes].
Maia FF; Araújo LR
J Pediatr (Rio J); 2005; 81(4):293-7. PubMed ID: 16106313
[TBL] [Abstract][Full Text] [Related]
8. What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?
Larsen J; Ford T; Lyden E; Colling C; Mack-Shipman L; Lane J
Endocr Pract; 2004; 10(4):324-9. PubMed ID: 15760775
[TBL] [Abstract][Full Text] [Related]
9. Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus.
Alemzadeh R; Loppnow C; Parton E; Kirby M
Diabetes Technol Ther; 2003; 5(2):167-73. PubMed ID: 12871606
[TBL] [Abstract][Full Text] [Related]
10. Performance comparison of the medtronic sof-sensor and enlite glucose sensors in inpatient studies of individuals with type 1 diabetes.
Calhoun P; Lum J; Beck RW; Kollman C
Diabetes Technol Ther; 2013 Sep; 15(9):758-61. PubMed ID: 23725474
[TBL] [Abstract][Full Text] [Related]
11. Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion.
Radermecker RP; Fayolle C; Brun JF; Bringer J; Renard E
Diabetes Metab; 2013 May; 39(3):258-62. PubMed ID: 23522730
[TBL] [Abstract][Full Text] [Related]
12. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.
Garg S; Zisser H; Schwartz S; Bailey T; Kaplan R; Ellis S; Jovanovic L
Diabetes Care; 2006 Jan; 29(1):44-50. PubMed ID: 16373894
[TBL] [Abstract][Full Text] [Related]
13. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis.
Mirani M; Berra C; Finazzi S; Calvetta A; Radaelli MG; Favareto F; Graziani G; Badalamenti S
Diabetes Technol Ther; 2010 Oct; 12(10):749-53. PubMed ID: 20809678
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel short-term continuous subcutaneous insulin infusion program evaluated by continuous glucose monitoring on young adult type 1 diabetic patients in Taiwan.
Lin CH; Huang CH; Tsai JS; Hsieh SH; Sun JH; Huang BY; Huang MJ; Huang YY
Endocr J; 2011; 58(10):835-40. PubMed ID: 21828934
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
16. Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24-hour continuous blood glucose monitoring.
Arias P; Kerner W; Zier H; Navascués I; Pfeiffer EF
Diabetes Care; 1985; 8(2):134-40. PubMed ID: 3888562
[TBL] [Abstract][Full Text] [Related]
17. Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.
Deiss D; Kordonouri O; Hartmann R; Hopfenmüller W; Lüpke K; Danne T
Pediatr Diabetes; 2007 Jun; 8(3):157-62. PubMed ID: 17550426
[TBL] [Abstract][Full Text] [Related]
18. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
[TBL] [Abstract][Full Text] [Related]
19. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.
Boland E; Monsod T; Delucia M; Brandt CA; Fernando S; Tamborlane WV
Diabetes Care; 2001 Nov; 24(11):1858-62. PubMed ID: 11679447
[TBL] [Abstract][Full Text] [Related]
20. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
